Actionable insights straight to your inbox

Equities logo

GlaxoSmithKline’s Trademark Application for “COMMITMENT TO ACCESS” Filed

By a News Reporter-Staff News Editor at Pharma Business Week -- According to news reporting originating from Washington, D.C., by NewsRx journalists, a trademark application has been made for

By a News Reporter-Staff News Editor at Pharma Business Week — According to news reporting originating from Washington, D.C., by NewsRx journalists, a trademark application has been made for “COMMITMENT TO ACCESS” by Christopher M Hanes, representing GlaxoSmithKline. This application was made available to the public on June 27, 2014 (see also Trademarks).
The serial number for this application is 78130796.
The international trademark goods and services class code for this trademark application is 044.
As submitted by the applicant, this trademark application relates to the following goods and services: Charitable services, namely providing indigent patients with prescription drugs together with information about pharmaceutical access and reimbursement programs.
The owner/registrar information for this application is: Christopher M Hanes, GlaxoSmithKline, LGTM, C.3157.3D, Five Moore Drive, Research Triangle Park NC 27709.
Keywords for this news article include: Pharmaceutical Companies, Trademarks, GlaxoSmithKline.
Our reports deliver fact-based news of research and discoveries from around the world. Copyright 2014, NewsRx LLC

A weekly five-point roundup of critical events in fintech, the future of finance and the next wave of banking industry transformation.